StratifiCare Pte. Ltd.

06/06/2025

🚨Can we predict if liver cancer patients will respond to — before treatment begins?

At the recent SEA & ANZ CytoFLEX User Group Meeting hosted by Beckman Coulter Life Sciences Beckman Coulter Life Sciences, our R&D Scientist Trinda Anne Ting presented preliminary data on — ’s AI-powered blood test developed on Beckman Coulter Life Sciences’ clinical flow cytometer.

💡 Yttrium-90 radioembolization (Y90-RE) is a targeted therapy for liver cancer that delivers tiny radioactive beads directly into liver tumours. This localised treatment leads to reduced side effects as compared to chemotherapy. A sustained response results in delayed disease progression and even significant tumour shrinkage. This means that inoperable patients can be converted into surgical candidates, giving them a real shot at long-term survival.

But the challenge? Not all patients respond well, and currently, doctors have no reliable way to predict treatment response.

That’s where StratifiREY comes in.

🧪 From just a blood draw, StratifiREY helps identify which patients are more likely to respond to Y90-RE. This enables oncologists to make faster, better-informed treatment decisions in the best interests of both the patient and the hospital.

✅ Our early results show high predictive accuracy, and we're excited about its potential impact on personalizing liver cancer treatment.

💬 Interested to learn more or explore collaboration opportunities?
Reach out, we’d love to connect!

03/04/2025

Thrilled to be featured by NUS Enterprise, sharing StratifiCare’s journey from a research lab at the National University of Singapore to a global player in predictive medical diagnostics! Our mission with is clear — help healthcare providers deliver the right care for patients while easing the strain on healthcare systems.

As we continue to develop and scale StratifiDen, we’re actively raising catalytic funding to make a lasting impact in and developing countries where Dengue poses a critical challenge. If you’re passionate about transforming healthcare and want to support our mission in any way, let’s connect!

Special thanks to NUS Enterprise for the continued support and belief in our vision.

👉 Read the full article: https://www.linkedin.com/pulse/personalising-treatment-dengue-patients-worldwide-nusenterprise-jtfcc/

27/02/2025

A huge shout-out to Shankar Pattabhiraman, Vinu Varghese, and Anandh Banu for their incredible hospitality during my visit to Beckman Coulter Life Sciences in , !

Touring their world-class R&D and GMP manufacturing facilities was truly eye-opening—India is solidifying its place as a global leader in cutting-edge medical diagnostics technologies. Seeing firsthand the expertise and innovation driving Beckman Coulter Life Sciences' operations only reinforces the potential of what we can achieve together.

As we push the boundaries of precision diagnostics in nuclear medicine, we look forward to an even closer collaboration with Beckman Coulter Life Sciences—driving innovation and shaping the future of cancer treatment. Exciting times ahead!

Also, a big thank you to XY and Yolanda Gan for making this visit possible.

08/08/2024

🚨WHO Recognizes Dengue Virus as a High Pandemic Risk🚨

Dengue virus was added to the World Health Organization (WHO) list of the most dangerous viruses and bacteria in their latest update made earlier this year in June. This list, formulated by over 200 scientists from more than 50 countries, encompasses they believe have a high likelihood of threatening to cause the next and . was considered to have a high public health emergency of international concern ( ) risk in every global region.

Why is Dengue Dangerous?
• Highly Transmissible: Spread by mosquitoes, Dengue affects millions and claims the lives of thousands annually. These numbers only worsen with global warming, increased urbanization, and after natural disasters 🦟
• Severe Health Impact: Can cause severe flu-like symptoms and, in extreme cases, lead to dengue hemorrhagic fever which is life-threatening without proper treatment 💉
• Limited Treatments: No specific antiviral treatment is available, making prevention and early detection crucial 🕒

The purpose of this list is to identify priority pathogens for organizations to focus their efforts on. These are diseases that we need to develop treatments, vaccines, diagnostics, and other solutions in the event of a country or worldwide outbreak.

StratifiCare is answering this call-to-action! Our product, , is one of these solutions. StratifiDen can help hospitals identify patients in advance in those extreme cases that will develop dengue hemorrhagic fever. This is vital to the early differentiation of Dengue patients who require intense hospital care from patients who can receive treatment at home. StratifiDen is a revolutionizing solution to the high-risk Dengue fever that can save lives and resources for both patients and hospitals.

Help us get our solution to the deadly Dengue virus out to the world! 🌎

This document outlines the findings of a global pathogen prioritization process involving over 200 scientists from more than 50 countries who evaluated the evidence related to 28 Viral Families and one core group of Bacteria, encompassing 1,652 pathogens. This process emphasized the imperative natur...

01/08/2024

💫 TS2 Accelerator Demo Day 💫

Last Thursday, we had the opportunity to speak to an audience of investors, companies, and fellow start-ups as we pitched our company at the inaugural TS2 Demo Day. This event was a culmination of 10 weeks of hard work, learning, and collaboration as a part of the National University of Singapore Enterprise Technology For Sustainable Social Impact (TS2) Accelerator. 🗣️

The TS2 Accelerator, a joint initiative by NUS Enterprise and the Singapore Centre for Social Enterprise, raiSE SG, has been an incredibly valuable experience. This 10-week program provided mentorship, networking opportunities, and a supportive community, all committed to driving sustainable social impact through technology. 🤝

Our Co-founder and CEO Anthony Chua was honored to be interviewed by Kong Yu Hui for an article in Lianhe Zaobao 联合早报 about the TS2 Accelerator. Thank you for the opportunity to share about this experience and highlight the benefits of our product StratifiDen on the issue of over-hospitalization. The article is linked below if you would like to read it. 📰

It was so empowering to see the efforts of each of these start-ups come to fruition. We wish each of our fellow cohort mates the best and hope to see the ways their innovations will grow and make impact in the future. 🚀

We are grateful to NUS Enterprise and raiSE SG for their support and commitment to nurturing social enterprises. Thank you Block71 Singapore, for hosting and organizing this event. Finally, special thanks to our mentor, Adam Lyle, for all the time, wisdom, guidance, and patience you gave us throughout this program. Your support has been invaluable to our company and the advice you have given will continue to shape our progress and success. 🙏

To every person we had the chance to speak to, thank you for your time, We hope to reconnect if you would like to help us make an impact with our product. Help us reduce over-hospitalization, save hospital resources, and patient lives. 🏥

If you want to learn more about our company and products, or join us on our journey of making a positive social impact, follow us on LinkedIn or reach out at general@stratificare.com. 🌍



🔗https://www.zaobao.com.sg/news/singapore/story20240725-4360126

18/07/2024

💡 InnovFest with TS2 Accelerator💡
We had an incredible time at , where we had the opportunity to showcase our innovative solutions and connect with industry leaders and other startups.

InnovFest x Elevating Founders is Asia’s largest showcase featuring university start-ups and the official start-up event of 2024. It provides a unique platform to see academia and industry come together to revolutionize technology and drive innovation. 📚⚙️

Our founders Anthony Chua and Tiffany Fan Lin showcased StratifiCare's two pioneering products, and . StratifiDen is a severe Dengue prediction test, capable of saving lives, hospital and patient resources, and making huge social impacts in developing countries. StratifiREY can predict the effectiveness of as a treatment for liver cancer patients. Our innovations integrate protein diagnostics with technology to provide predictive diagnostic tests to help patients and healthcare providers make well-informed healthcare decisions. ⚕️

Thank you National University of Singapore Enterprise and Elevating Founders for organizing this event. Our participation in InnovFest was made possible by a generous sponsorship from NUS Enterprise and raiSE SG, as part of the TS2 Accelerator. 🤝

Our experience at InnovFest has been pivotal in our growth, providing us with invaluable connections and insights. We had amazing conversations with industry leaders, experts, and innovators, and are grateful for the support we received. It was rewarding to see fellow TS2 Accelerators members displaying their work. We are inspired by the talent and dedication we witnessed and look forward to making impacts across Asia and beyond with our products. 🌏

11/07/2024

🌟Highlights from Echelon X🌟

We were honored to be invited to participate in Echelon X at Prudence Foundation’s Pavilion alongside other startups in the SAFE STEPS D-Tech Community. These consist of startups dedicated to technologies that can aid in the impact of natural disasters, prevent them, or expedite recovery efforts. 🚑

Our Co-founder and CEO Anthony Chua was given the opportunity to present how our product is making a difference in communities affected by natural disasters. Following events such as floods or hurricanes, there is an abundance of standing water that becomes the perfect breeding ground for mosquitoes. This leads to an outbreak of fever. Hospitals already caring for patients injured during the disaster or infected by waterborne diseases become even more overwhelmed by Dengue fever patients, most of whom can be treated at home. This depletes hospitals of space, supplies, and caretakers. StratifiDen can accurately identify if a patient will develop severe Dengue and require hospitalization. This allows hospitals to provide necessary care to the patients that need it most while saving time and hospital beds when these resources are the most vital. 🩺 🏥

Thank you to the Prudence Foundation and e27 (Optimatic) for hosting this event and their partners the International Federation of Red Cross and Red Crescent Societies - IFRC and Amazon Web Services (AWS).

Special thanks to the Prudence Foundation SAFE STEPS D-Tech Program for sponsoring us. We appreciate the opportunity to bring awareness to solutions to post-disaster disease . This program is pivotal in driving advancements that can save lives and mitigate the impact of natural disasters. We are proud to have been part of such an impactful initiative and contribute to the collaborative effort against natural calamities. 🤝

02/07/2024

Watch this video to see GISAID's recap of the Arbovirus Summit where our CEO and co-founder Anthony Chua was invited to speak. 📽

Thank you to the GISAID Initiative, the Ministry of Health of the Republic of Indonesia, and the Ministry of Health of Brazil for the opportunity to share about our innovation , and how it can help provide relief against the pandemic. 🙌

02/07/2024

📢StratifiCare at the International Arbovirus Summit📢

We are excited to announce that our Co-founder and CEO, Dr. Anthony Chua, was invited to speak at the International Arbovirus Summit in Indonesia. Hosted by the Ministry of Health of the Republic of Indonesia and the Ministry of Health of Brazil at The GISAID Initiative Academy on the United In Diversity Indonesia Bali campus, the summit was a pivotal event for advancing global health.

Anthony discussed our groundbreaking innovation , a panel of capable of predicting Hemorrhagic Fever. This biomarker panel leads its field in accurately identifying high-risk patients, saving valuable time and resources. StratifiDen is highly useful for minimizing the loss of patient lives and optimizing the allocation of precious healthcare resources. 💉

🌟In line with GISAID’s mission to promote the sharing of virus data for collaborative research efforts, this summit provided a valuable platform for exchanging knowledge and forging connections with global health experts and leading researchers to address the rising of mosquito-borne diseases. Anthony spoke with leaders like Dr. Yu Kie Chem, the Head of Virology at the National Public Health Laboratory in Malaysia, discussing the pressing need for innovative solutions to advance global health and strengthen the management and surveillance of arboviruses.

We are proud to be at the forefront of the fight against the Dengue and honored to be invited to share our contributions to combat the spread of . With innovations like StratifiDen, we can create a healthier and safer world.

Stay tuned for more updates and join us in our mission of revolutionizing healthcare and transforming lives globally!

🌏 💡 🤝 🔬

04/04/2024

Don't underestimate ! 🚨 Climate change, urbanization and air travel are fuelling its spread, posing serious health risks globally. Learn why you should care and how to protect yourself in this informative video by Dr. Raman Velayudhan from World Health Organization (WHO).

🌐As Dengue fever continues to capture media attention with daily increase in case counts, it is indisputable that Dengue will persist in its spread, impacting an increasing number of individuals. Stratification serves a crucial role in discerning the critical subset of patients, constituting less than 5% of all infected individuals, who will progress to develop severe Dengue. This aids hospitals by optimizing resource allocation, conserving beds for patients exhibiting greater clinical urgency.

Dr. Velayudhan delves into the causes contributing to the spread of the disease, revealing the supportive treatment options. Protect yourselves and people around you by focusing on eliminating mosquito breeding sites by removing stagnant water, using insect repellent, wearing protective clothing, and employing mosquito nets, especially during the daytime when Aedes mosquitoes are most active.

🌟 Our proudest innovation, , is a game-changer in the battle against the rising threat of Dengue epidemics worldwide. With the Dengue epidemic once again gripping nations like Brazil and Peru, it is crucial to have proactive solutions in place. Our ground-breaking severe Dengue prediction test empowers healthcare professionals to identify high-risk patients swiftly and early, saving crucial time and resources in the fight against this deadly disease. Together, let's pave the way for a healthier, more resilient future.

🌍💉🔬

Why is Dengue fever spreading to places it did not exist before? What are the symptoms and treatments? What about vaccines? Dr Raman Velayudhan explains in S...

28/03/2024

StratifiCare was proud to present at the SAFE STEPS D-Tech Community Hub Launch hosted by e27 , IFRC , and Prudence Foundation on Tuesday. Our CEO, Anthony Chua, joined pioneers in discussing disaster tech (D-tech). It's inspiring to witness collective efforts driving innovation for disaster resilience. At , we're committed to revolutionizing medical diagnostics with our predictive protein diagnostics and advanced AI. Our test predicts severe , saving lives and optimizing healthcare resource allocation, especially in post-flood outbreaks. Thank you for spotlighting us among tech startups. Wishing Hub a great success! Our dedication persists in transforming medical diagnostics and disaster resilience!

19/03/2024

🎉 Exciting news! StratifiCare Pte. Ltd. has been featured in an article discussing why is emerging as a frontrunner in , highlighting our contribution to the Singapore ecosystem. With our groundbreaking marriage of predictive protein and , we're driving advancements in personalized medicine. Stay tuned as we revolutionize , including tests for severe complications and cancer efficacy, to improve patient outcomes! Thank you, Biospectrum Asia, for featuring us!

🚀🔬

Why Singapore is Deep Tech Innovation Frontrunner